Show Summary Details
Page of

Acute Renal Failure 

Acute Renal Failure
Acute Renal Failure

Mazen O. Al-Qadi

and Amy W. Williams

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 January 2021

Tumor lysis syndrome (TLS) is a common emergency encountered in patients with hematologic malignancies. It is caused by the massive release of intracellular toxic metabolites when malignant tumor cells die (or by high rates of purine metabolism in spontaneous TLS). The syndrome develops within hours to days (up to 7 days) after initiation of chemotherapy and is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. If not treated promptly, these metabolic derangements may result in acute kidney injury, metabolic acidosis, arrhythmias, and death.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.